Method Of Inducing The Production Of Protective Anti-hiv-1 Antibodies

Abstract

The present invention relates, in general, to an immunogen for HIV vaccination and, in particular, to a method of inducing the production of protective anti-HIV antibodies by targeting B cell germline and clone intermediates using a combination of HIV envelope and non-HIV immunogens. The invention also relates to compositions suitable for use in such a method.


Claims
Inventors

Sign in to the Lens

Feedback